Human papillomavirus and p53 expression in cancer of unknown primary in the head and neck region in relation to clinical outcome (original) (raw)

Human papillomavirus, p16 and p53 expression associated with survival of head and neck cancer

Lubomir Turek

Infectious Agents and Cancer, 2010

View PDFchevron_right

Association between p53 and Human Papillomavirus in Head and Neck Cancer Survival

Lubomir Turek

Cancer Epidemiology Biomarkers & Prevention, 2008

View PDFchevron_right

Survival of patients with head and neck squamous cell carcinoma in association with human papillomavirus and p53 polymorphism

Ting Hway Wong

Open Medicine, 2012

View PDFchevron_right

p53 gene mutations and HPV infection in primary head and neck squamous cell carcinomas do not correlate with overall survival: a long term follow‐up study

Horst Schlechte

Journal of Oral Pathology & Medicine, 1997

View PDFchevron_right

High-Risk Human Papillomavirus Affects Prognosis in Patients With Surgically Treated Oropharyngeal Squamous Cell Carcinoma

marco alessandro pierotti

Journal of Clinical Oncology, 2006

View PDFchevron_right

Human papillomavirus in head and neck squamous cell carcinoma of unknown primary is a common event and a strong predictor of survival

Lena Specht

PloS one, 2014

View PDFchevron_right

Molecular analyses of unselected head and neck cancer cases demonstrates that human papillomavirus transcriptional activity is positively associated with survival and prognosis

Holger Sudhoff

BMC Cancer, 2016

View PDFchevron_right

Human papillomavirus and p16 immunostaining, prevalence and prognosis of squamous carcinoma of unknown primary in the head and neck region

Wei Xu

International Journal of Cancer, 2019

View PDFchevron_right

Inverse Relationship between Human Papillomavirus16 Infection and Disruptive p53 Gene Mutations in Squamous Cell Carcinoma of the Head and Neck

Shahnaz Begum

Clinical Cancer Research, 2008

View PDFchevron_right

Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer

susanto saint

View PDFchevron_right

Prognostic factors for head and neck cancer of unknown primary including the impact of human papilloma virus infection

Jan Nyman

Journal of otolaryngology - head & neck surgery = Le Journal d'oto-rhino-laryngologie et de chirurgie cervico-faciale, 2017

View PDFchevron_right

The Relationship Between Human Papillomavirus Status and Other Molecular Prognostic Markers in Head and Neck Squamous Cell Carcinomas

Nader Pourmand

International Journal of Radiation Oncology*Biology*Physics, 2009

View PDFchevron_right

Human papillomavirus and overall survival after progression of oropharyngeal squamous cell carcinoma

Phuc Nguyen-tan, Quynh-thu Le

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2014

View PDFchevron_right

Human papillomavirus and p53 mutations in head and neck squamous cell carcinoma among Japanese population

Takeshi Todo

Cancer Science, 2014

View PDFchevron_right

Evidence for different molecular parameters in head and neck squamous cell carcinoma of nonsmokers and nondrinkers: Systematic review and meta‐analysis on HPV , p16 , and TP53

Laura Baijens

Head & neck, 2020

View PDFchevron_right

Evidence for a Causal Association Between Human Papillomavirus and a Subset of Head and Neck Cancers

Richard Daniel

Journal of the National Cancer Institute, 2000

View PDFchevron_right

Human papilloma virus in head and neck cancers-role and relevance in clinical management

Vijayalakshmi Ramshankar

Indian journal of surgical oncology, 2013

View PDFchevron_right

A Review of Literature Pertaining to Head and Neck Squamous Cell Carcinoma with Emphasis on the Role of the Human Papilloma Virus

Sam Cartwright

International Journal of Otolaryngology and Head & Neck Surgery

View PDFchevron_right

Occurrence of p53 gene deletions and human papilloma virus infection in human head and neck cancer

Edward Dunphy

Cancer research, 1992

View PDFchevron_right

Molecular Pathogenesis, Epidemiology, Risk Factors & Prognosis of Head and Neck Cancers in Relation to Human Papilloma Virus Infection

rasel ahmad

Annals of King Edward Medical University, 2007

View PDFchevron_right

Human Papillomavirus Drives Tumor Development Throughout the Head and Neck: Improved Prognosis Is Associated With an Immune Response Largely Restricted to the Oropharynx

Christian Ottensmeier

Journal of Clinical Oncology, 2016

View PDFchevron_right

Human papillomavirus in head and neck cancer: Molecular biology and clinicopathological correlations

Judit Kurcsics, Erika Tóth

Cancer and Metastasis Reviews, 2005

View PDFchevron_right

Human papillomavirus predicts outcome in oropharyngeal cancer in patients treated primarily with surgery or radiation therapy

Jonathan Clark

British Journal of Cancer, 2010

View PDFchevron_right

Validation of Human Papillomavirus as a Favourable Prognostic Marker and Analysis of CD8(+) Tumour-infiltrating Lymphocytes and Other Biomarkers in Cancer of Unknown Primary in the Head and Neck Region

Tina Dalianis

Anticancer research, 2017

View PDFchevron_right

Low human papillomavirus prevalence in head and neck cancer: results from two large case-control studies in high-incidence regions

Vladimir Bencko

International Journal of Epidemiology, 2011

View PDFchevron_right

Long‐term Survival in Head and Neck Cancer: Impact of Site, Stage, Smoking, and Human Papillomavirus Status

B. Abedi

The Laryngoscope, 2019

View PDFchevron_right

The Role of the p16 and p53 Tumor Suppressor Proteins and Viral HPV16 E6 and E7 Oncoproteins in the Assessment of Survival in Patients with Head and Neck Cancers Associated with Human Papillomavirus Infections

Modra Murovska

Cancers, 2023

View PDFchevron_right

Overexpression of p53 and bcl-2 proteins and the presence of HPV infection are independent events in head and neck cancer

A. Bartolazzi

Journal of Oral Pathology and Medicine, 2000

View PDFchevron_right